Related Experiment Videos
Chronic obstructive pulmonary disease and respiratory complications
Anesthesia and Analgesia
|November 1, 1983
Summary
This study found that halothane and isoflurane anesthesia are equally safe for patients with chronic obstructive pulmonary disease (COPD), showing similar respiratory complication rates. Tachycardia was more common with isoflurane.
Area of Science:
- Anesthesiology
- Pulmonary Medicine
- Critical Care
Background:
- Chronic obstructive pulmonary disease (COPD) presents unique challenges for general anesthesia.
- Choosing the appropriate anesthetic agent is crucial for managing respiratory complications in COPD patients.
Purpose of the Study:
- To compare the safety and efficacy of halothane (H) versus isoflurane (I) for general anesthesia in patients with COPD.
- To evaluate intra- and postoperative respiratory complications associated with H and I anesthesia in this patient population.
Main Methods:
- A randomized study involving 148 COPD patients undergoing general anesthesia.
- Patients were randomly assigned to receive either halothane (N=74) or isoflurane (N=74).
- Analysis of 110 pre-, intra-, and postoperative variables, including respiratory complications.
Main Results:
- No significant differences were observed between halothane and isoflurane groups for most variables.
- Tachycardia occurred significantly more frequently in the isoflurane group.
- Log-linear analyses indicated no interactions between anesthetic groups, non-outcome variables, and complications.
Conclusions:
- Halothane and isoflurane are associated with similar outcomes and incidences of respiratory complications in COPD patients.
- Both anesthetic agents appear to be suitable for general anesthesia in this patient group, with careful monitoring for tachycardia advised for isoflurane.